标题
Preclinical Models of Visceral Sarcomas
作者
关键词
-
出版物
Biomolecules
Volume 13, Issue 11, Pages 1624
出版商
MDPI AG
发表日期
2023-11-06
DOI
10.3390/biom13111624
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell‐derived neural crest cells
- (2023) Kyosuke Mukae et al. CANCER SCIENCE
- Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research
- (2023) Lorena Landuzzi et al. Cancers
- Photon and Proton irradiation in Patient-derived, Three-Dimensional Soft Tissue Sarcoma Models
- (2023) Siyer Roohani et al. BMC CANCER
- Editorial: Patient-derived tumor models for drug development
- (2023) Hatim E. Sabaawy et al. Frontiers in Oncology
- Current molecular and therapeutic advances in liposarcoma, rhabdomyosarcoma, leiomyosarcoma, synovial sarcoma, and angiosarcoma
- (2022) Ozgur Tanriverdi et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression
- (2022) Matthew L. Hemming et al. CLINICAL CANCER RESEARCH
- Patient Derived Ex-Vivo Cancer Models in Drug Development, Personalized Medicine, and Radiotherapy
- (2022) Ryan Zitter et al. Cancers
- Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation
- (2021) Valentina Zuco et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Preclinical In Vivo Modeling of Pediatric Sarcoma—Promises and Limitations
- (2021) Roland Imle et al. Journal of Clinical Medicine
- Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
- (2021) A. Gronchi et al. ANNALS OF ONCOLOGY
- Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2021) P.G. Casali et al. ANNALS OF ONCOLOGY
- Generation of human embryonic stem cell models to exploit the EWSR1-CREB fusion promiscuity as a common pathway of transformation in human tumors
- (2021) Fabio Vanoli et al. ONCOGENE
- Eribulin activity in soft tissue sarcoma monolayer and three-dimensional cell line models: could the combination with other drugs improve its antitumoral effect?
- (2021) Javier Escudero et al. Cancer Cell International
- Glucose transporter‑1 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cells
- (2021) Takafumi Shima et al. ONCOLOGY REPORTS
- Patient-derived iPSCs link elevated mitochondrial respiratory complex I function to osteosarcoma in Rothmund-Thomson syndrome
- (2021) Brittany E. Jewell et al. PLoS Genetics
- The role of novel fusion genes in human GIST cell lines derived from imatinib-resistant GIST patients: A therapeutic potential of fusion gene
- (2020) Woo-Cheol Cho et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Three-Dimensional Culture System of Cancer Cells Combined with Biomaterials for Drug Screening
- (2020) Teruki Nii et al. Cancers
- HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer
- (2020) Rita Lombardi et al. Molecular Oncology
- Systematic Review of the Current Status of Human Sarcoma Cell Lines
- (2019) Emi Hattori et al. Cells
- First-Line Therapy for Metastatic Soft Tissue Sarcoma
- (2019) Megan Meyer et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas
- (2019) Bertha A. Brodin et al. BRITISH JOURNAL OF CANCER
- Establishment and characterization of histologically and molecularly stable soft tissue sarcoma xenograft models for biological studies and preclinical drug testing
- (2019) Jasmien Cornillie et al. MOLECULAR CANCER THERAPEUTICS
- Development of mouse models of angiosarcoma driven by p53
- (2019) Donald M. Salter et al. Disease Models & Mechanisms
- Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived Xenograft
- (2019) Silvia Stacchiotti et al. Cancers
- A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation
- (2019) François Le Loarer et al. MODERN PATHOLOGY
- Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy
- (2018) Minan Wang et al. FASEB JOURNAL
- Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcome
- (2018) Matthew L. Hemming et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A review of soft-tissue sarcomas: translation of biological advances into treatment measures
- (2018) Ngoc T Hoang et al. Cancer Management and Research
- Transgenic Mouse Models in Cancer Research
- (2018) Ursa Lampreht Tratar et al. Frontiers in Oncology
- Activated tyrosine kinases in gastrointestinal stromal tumor with loss of KIT oncoprotein expression
- (2018) Yuqing Tu et al. CELL CYCLE
- Soft Tissue Sarcoma Cancer Stem Cells: An Overview
- (2018) Katia C. Genadry et al. Frontiers in Oncology
- Zebrafish xenograft models of cancer and metastasis for drug discovery
- (2017) Hannah K Brown et al. Expert Opinion on Drug Discovery
- Orthotopic patient-derived xenografts of paediatric solid tumours
- (2017) Elizabeth Stewart et al. NATURE
- A Trp53fl/flPtenfl/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging
- (2017) Marisa R. Buchakjian et al. PLoS One
- Managing sarcoma: where have we come from and where are we going?
- (2017) Jenna S. Bleloch et al. Therapeutic Advances in Medical Oncology
- Three-Dimensional Patient-Derived In Vitro Sarcoma Models: Promising Tools for Improving Clinical Tumor Management
- (2017) Manuela Gaebler et al. Frontiers in Oncology
- Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines
- (2016) Abdulazeez Salawu et al. BRITISH JOURNAL OF CANCER
- Patient-derived xenografts: a relevant preclinical model for drug development
- (2016) Luca Pompili et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cabozantinib Is Active against Human Gastrointestinal Stromal Tumor Xenografts Carrying Different KIT Mutations
- (2016) Yemarshet K. Gebreyohannes et al. MOLECULAR CANCER THERAPEUTICS
- Patient-derived induced pluripotent stem cells in cancer research and precision oncology
- (2016) Eirini P Papapetrou NATURE MEDICINE
- An EWS-FLI1 -Induced Osteosarcoma Model Unveiled a Crucial Role of Impaired Osteogenic Differentiation on Osteosarcoma Development
- (2016) Shingo Komura et al. Stem Cell Reports
- Modeling Familial Cancer with Induced Pluripotent Stem Cells
- (2015) Dung-Fang Lee et al. CELL
- Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression
- (2015) B. A. Teicher et al. MOLECULAR CANCER THERAPEUTICS
- Genomic landscape of liposarcoma
- (2015) Deepika Kanojia et al. Oncotarget
- SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier
- (2015) Sakura Tamaki et al. PLoS One
- Phosphoinositide 3-Kinase Inhibitors Combined with Imatinib in Patient-Derived Xenograft Models of Gastrointestinal Stromal Tumors: Rationale and Efficacy
- (2014) T. Van Looy et al. CLINICAL CANCER RESEARCH
- Ponatinib Inhibits Polyclonal Drug-Resistant KIT Oncoproteins and Shows Therapeutic Potential in Heavily Pretreated Gastrointestinal Stromal Tumor (GIST) Patients
- (2014) A. P. Garner et al. CLINICAL CANCER RESEARCH
- TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities
- (2014) Christian Koelsche et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models
- (2014) Haifu Li et al. Translational Oncology
- Novel Dedifferentiated Liposarcoma Xenograft Models Reveal PTEN Down-Regulation as a Malignant Signature and Response to PI3K Pathway Inhibition
- (2013) Kathleen B. Smith et al. AMERICAN JOURNAL OF PATHOLOGY
- Gastrointestinal Stromal Tumors
- (2013) Markku Miettinen et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- The Clinical Relevance of Cancer Cell Lines
- (2013) J.-P. Gillet et al. JNCI-Journal of the National Cancer Institute
- Sorafenib Inhibits Many Kinase Mutations Associated with Drug-Resistant Gastrointestinal Stromal Tumors
- (2012) M. C. Heinrich et al. MOLECULAR CANCER THERAPEUTICS
- Patient-derived tumour xenografts as models for oncology drug development
- (2012) John J. Tentler et al. Nature Reviews Clinical Oncology
- Metabolomics Strategy Reveals Subpopulation of Liposarcomas Sensitive to Gemcitabine Treatment
- (2012) D. Braas et al. Cancer Discovery
- Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations
- (2011) Stine H. Kresse et al. CANCER
- Small RNA Sequencing and Functional Characterization Reveals MicroRNA-143 Tumor Suppressor Activity in Liposarcoma
- (2011) S. Ugras et al. CANCER RESEARCH
- Expression Profiling of Liposarcoma Yields a Multigene Predictor of Patient Outcome and Identifies Genes That Contribute to Liposarcomagenesis
- (2011) R. M. Gobble et al. CANCER RESEARCH
- Restoration of C/EBPα in dedifferentiated liposarcoma induces G2/M cell cycle arrest and apoptosis
- (2011) Yuhsin V. Wu et al. GENES CHROMOSOMES & CANCER
- Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
- (2011) J.-P. Gillet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frequent Alterations and Epigenetic Silencing of Differentiation Pathway Genes in Structurally Rearranged Liposarcomas
- (2011) B. S. Taylor et al. Cancer Discovery
- Local Mesenchymal Stem/Progenitor Cells Are a Preferential Target for Initiation of Adult Soft Tissue Sarcomas Associated with p53 and Rb Deficiency
- (2010) Jinhyang Choi et al. AMERICAN JOURNAL OF PATHOLOGY
- Patterning network structure to spatially control cellular remodeling and stem cell fate within 3-dimensional hydrogels
- (2010) Sudhir Khetan et al. BIOMATERIALS
- ZIC1 Overexpression Is Oncogenic in Liposarcoma
- (2010) E. Brill et al. CANCER RESEARCH
- A decade of tyrosine kinase inhibitor therapy: Historical and current perspectives on targeted therapy for GIST
- (2010) Jean-Yves Blay CANCER TREATMENT REVIEWS
- Animal models of soft-tissue sarcoma
- (2010) R. D. Dodd et al. Disease Models & Mechanisms
- Credentialing a Preclinical Mouse Model of Alveolar Rhabdomyosarcoma
- (2009) K. Nishijo et al. CANCER RESEARCH
- Inhibitors of Deacetylases Suppress Oncogenic KIT Signaling, Acetylate HSP90, and Induce Apoptosis in Gastrointestinal Stromal Tumors
- (2009) T. Muhlenberg et al. CANCER RESEARCH
- High Efficacy of Panobinostat Towards Human Gastrointestinal Stromal Tumors in a Xenograft Mouse Model
- (2009) G. Floris et al. CLINICAL CANCER RESEARCH
- Mouse xenograft models vs GEM models for human cancer therapeutics
- (2008) A. Richmond et al. Disease Models & Mechanisms
- Chemotherapeutic Management of Soft Tissue Sarcoma
- (2008) Katherine Thornton SURGICAL CLINICS OF NORTH AMERICA
- Characterization of the 12q amplicons by high-resolution, oligonucleotide array CGH and expression analyses of a novel liposarcoma cell line
- (2007) Fredrik Persson et al. CANCER LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started